Investor presentation First half of 2016
... • Superiority of Victoza® vs placebo was confirmed for time to first MACE in people with type 2 diabetes at high CV risk ...
... • Superiority of Victoza® vs placebo was confirmed for time to first MACE in people with type 2 diabetes at high CV risk ...
Guide to Infusion Site Management
... Guide to Infusion Site Management This guide is designed as a reference for healthcare professionals and the insulin pump wearers they work with. There may be several equally valid methods regarding infusion site management for arriving at the same therapeutic outcome. In this guide, we describe th ...
... Guide to Infusion Site Management This guide is designed as a reference for healthcare professionals and the insulin pump wearers they work with. There may be several equally valid methods regarding infusion site management for arriving at the same therapeutic outcome. In this guide, we describe th ...
Type 2 diabetes: newer agents for blood glucose control in type 2
... People with type 2 diabetes should have the opportunity to make informed decisions about their care and treatment, in partnership with their healthcare professionals. If patients do not have the capacity to make decisions, healthcare professionals should follow the Department of Health (2001) guidel ...
... People with type 2 diabetes should have the opportunity to make informed decisions about their care and treatment, in partnership with their healthcare professionals. If patients do not have the capacity to make decisions, healthcare professionals should follow the Department of Health (2001) guidel ...
early detection, diagnosis and intervention for
... diabetes in symptomatic individuals. For asymptomatic individuals, biochemical assessment is essential. This may be achieved by fasting or random blood glucose measurement, confirmed through repeat testing or via an Oral Glucose Tolerance Test. From a practical point of view, random blood testing is ...
... diabetes in symptomatic individuals. For asymptomatic individuals, biochemical assessment is essential. This may be achieved by fasting or random blood glucose measurement, confirmed through repeat testing or via an Oral Glucose Tolerance Test. From a practical point of view, random blood testing is ...
Inpatient diabetes care: evaluation and intervention.
... described. These conditions promote a decrease in insulin secretion and induce an increase in insulin resistance. Protection against adverse outcomes may be influenced by numerous metabolic and non-metabolic mechanisms related to control of hyperglycaemia.15 ...
... described. These conditions promote a decrease in insulin secretion and induce an increase in insulin resistance. Protection against adverse outcomes may be influenced by numerous metabolic and non-metabolic mechanisms related to control of hyperglycaemia.15 ...
The use of PET-CT for cancer staging in Italy
... Basilicata and Trento, collected new data on T1DM diffusion in their own context, sharing a common methodology, so that a clearer picture of the actual diffusion of the disease and its main long and short term consequences are given. Chapter 5 deals with patients’ views on SAP and its main component ...
... Basilicata and Trento, collected new data on T1DM diffusion in their own context, sharing a common methodology, so that a clearer picture of the actual diffusion of the disease and its main long and short term consequences are given. Chapter 5 deals with patients’ views on SAP and its main component ...
2011 ADA PubOnly 2042-2706.indd
... Little evidence is available on the relationship between HbA1c and indicators of glycemic variability. The aim of this study was to investigate the correlation between HbA1c and several parameters of glycemic control, hyperglycemia, and glycemic variability in Type 1 and Type 2 diabetic patients. We ...
... Little evidence is available on the relationship between HbA1c and indicators of glycemic variability. The aim of this study was to investigate the correlation between HbA1c and several parameters of glycemic control, hyperglycemia, and glycemic variability in Type 1 and Type 2 diabetic patients. We ...
diabetic ketoacidosis
... which this rise occurs, as glucose enters the pancreatic β cells and stimulates insulin release. Diabetes is a disease that affects glucose metabolism. There are essentially two types of diabetes: Type 1 (also called juvenile–onset diabetes) and type 2 (also called adult onset or non-insulin-depende ...
... which this rise occurs, as glucose enters the pancreatic β cells and stimulates insulin release. Diabetes is a disease that affects glucose metabolism. There are essentially two types of diabetes: Type 1 (also called juvenile–onset diabetes) and type 2 (also called adult onset or non-insulin-depende ...
Euro Diabetes Index 2014 - Health Consumer Powerhouse
... countries, an essential way to avoid complications. The awareness of the relation between lifestyle, manifest through diet and obesity, and diabetes has become stronger. Patient management by devices for self-monitoring and medication is spreading, a most important step to empower individuals. Patie ...
... countries, an essential way to avoid complications. The awareness of the relation between lifestyle, manifest through diet and obesity, and diabetes has become stronger. Patient management by devices for self-monitoring and medication is spreading, a most important step to empower individuals. Patie ...
Individualizing Therapy for the
... therapy should include not only effective glycemic control, but also avoidance of weight gain, hypoglycemic events, and development or worsening of cardiovascular risk factors. Criteria to assess these goals should be built into clinical trial protocols of new agents to treat T2DM.6 The pharmacist i ...
... therapy should include not only effective glycemic control, but also avoidance of weight gain, hypoglycemic events, and development or worsening of cardiovascular risk factors. Criteria to assess these goals should be built into clinical trial protocols of new agents to treat T2DM.6 The pharmacist i ...
Common risk factors associated with acute myocardial infarction
... Type 2 diabetes and Insulin resistance Diabetes mellitus is a disorder leading to chronic hyperglycaemia. The disorder involves disturbed metabolism of carbohydrates, fat, and protein, and is caused by defects in insulin secretion or insulin action, or both [19]. In type 1 diabetes there is a destru ...
... Type 2 diabetes and Insulin resistance Diabetes mellitus is a disorder leading to chronic hyperglycaemia. The disorder involves disturbed metabolism of carbohydrates, fat, and protein, and is caused by defects in insulin secretion or insulin action, or both [19]. In type 1 diabetes there is a destru ...
A Detailed Study on Poly Cystic Ovarian Syndrome
... 31% rate of impaired glucose tolerance and 7.5% met the criteria for type 2 diabetes mellitus.46The prevalence of type 2 diabetes has been reported to be higher among women with PCOS than women without PCOS .For type 2 diabetes mellitus, Metformin is the most widely studied agent thus far and most, ...
... 31% rate of impaired glucose tolerance and 7.5% met the criteria for type 2 diabetes mellitus.46The prevalence of type 2 diabetes has been reported to be higher among women with PCOS than women without PCOS .For type 2 diabetes mellitus, Metformin is the most widely studied agent thus far and most, ...
S PCO About
... We also recommend lifestyle interventions that may help with spontaneous ovulation. • Miscarriage – Women with PCOS may be at increased risk for spontaneous miscarriage. Contributing factors include elevated insulin levels (insulin resistance) and high levels of luteinizing hormone (LH) or androgen ...
... We also recommend lifestyle interventions that may help with spontaneous ovulation. • Miscarriage – Women with PCOS may be at increased risk for spontaneous miscarriage. Contributing factors include elevated insulin levels (insulin resistance) and high levels of luteinizing hormone (LH) or androgen ...
PEDS Diabetes - NurseCe4Less.com
... increased risk of diabetes since 1993 and did not find any link between vitamin D intake nor 25-hydroxyvitamin D levels during childhood to be linked with autoimmune destruction of the islets of Langerhans nor progression to type 1 diabetes mellitus.17 Another risk factor for the development of type ...
... increased risk of diabetes since 1993 and did not find any link between vitamin D intake nor 25-hydroxyvitamin D levels during childhood to be linked with autoimmune destruction of the islets of Langerhans nor progression to type 1 diabetes mellitus.17 Another risk factor for the development of type ...
Full version - 衞生署基層醫療統籌處Primary Care Office Department
... Advisory Committee and chaired by the Secretary for Food and Health was reconvened to discuss and provide strategic recommendations on enhancing and developing primary care in Hong Kong. Four Task Forces have been established to study specific proposals set out in the Healthcare Reform Consultation ...
... Advisory Committee and chaired by the Secretary for Food and Health was reconvened to discuss and provide strategic recommendations on enhancing and developing primary care in Hong Kong. Four Task Forces have been established to study specific proposals set out in the Healthcare Reform Consultation ...
NaDIA 2016 - Full Report - PowerPoint
... Notes: 1. This may be because these patients can self-test when they have symptoms. Other patients might just eat or drink something without a confirmatory test ...
... Notes: 1. This may be because these patients can self-test when they have symptoms. Other patients might just eat or drink something without a confirmatory test ...
new-onset diabetes after transplantation
... has been greatly underestimated in the literature because of the lack of a standard definition for the condition. Most definitions for diabetes after transplantation are derived from random glucose testing or fasting glucose levels greater than 140 mg/dL, and clinical trials do not routinely include ...
... has been greatly underestimated in the literature because of the lack of a standard definition for the condition. Most definitions for diabetes after transplantation are derived from random glucose testing or fasting glucose levels greater than 140 mg/dL, and clinical trials do not routinely include ...
Public Health Module Unit: Public Health
... The Greek Physician Aretaeus (30-90CE) gave diabetes its name, which means ‘a flowing through’ in recognition of the symptoms of constant thirst, excessive urination and loss of weight. Similarly before the 18th century the Japanese referred to diabetes mellitus as 'Shoukachi', the thirst disease. A ...
... The Greek Physician Aretaeus (30-90CE) gave diabetes its name, which means ‘a flowing through’ in recognition of the symptoms of constant thirst, excessive urination and loss of weight. Similarly before the 18th century the Japanese referred to diabetes mellitus as 'Shoukachi', the thirst disease. A ...
On Severe Hypoglycaemia in Children and Adolescents with Type 1 Diabetes
... body to lose its ability to utilise carbohydrates as fuel. As a result, glucose levels are elevated in the blood and spill into the urine, and fat and proteins are utilised to supply the body’s energy. The spilling of glucose in the urine causes the classical symptoms frequent increased urination, c ...
... body to lose its ability to utilise carbohydrates as fuel. As a result, glucose levels are elevated in the blood and spill into the urine, and fat and proteins are utilised to supply the body’s energy. The spilling of glucose in the urine causes the classical symptoms frequent increased urination, c ...
American Diabetes Association
... Recommendations: Detection and Diagnosis of GDM (2) • Screen women with GDM for persistent diabetes at 6–12 weeks postpartum, using OGTT, nonpregnancy diagnostic criteria (E) • Women with a history of GDM should have lifelong screening for the development of diabetes or prediabetes at least every 3 ...
... Recommendations: Detection and Diagnosis of GDM (2) • Screen women with GDM for persistent diabetes at 6–12 weeks postpartum, using OGTT, nonpregnancy diagnostic criteria (E) • Women with a history of GDM should have lifelong screening for the development of diabetes or prediabetes at least every 3 ...
New injection recommendations for patients with
... Supplement) and it went through several iterations both during and after that meeting. We have now arrived at a consensus document which is as robust as it can be given our current state of knowledge. The recommendations published here are thoroughly evidence-based. They stress the need for correct ...
... Supplement) and it went through several iterations both during and after that meeting. We have now arrived at a consensus document which is as robust as it can be given our current state of knowledge. The recommendations published here are thoroughly evidence-based. They stress the need for correct ...
Advancing the Science of Perceptual Accuracy
... Pennebaker, Gonder-Frederick, Cox, & Hoover, 1985). Assessment of perceptual accuracy in diabetes can also compare an observed measure of functioning (e.g., blood glucose) to estimated functioning predicted by the patient (e.g., patient prediction of blood glucose), termed blood glucose estimation a ...
... Pennebaker, Gonder-Frederick, Cox, & Hoover, 1985). Assessment of perceptual accuracy in diabetes can also compare an observed measure of functioning (e.g., blood glucose) to estimated functioning predicted by the patient (e.g., patient prediction of blood glucose), termed blood glucose estimation a ...
Advanced preparation of insulin syringes for adult
... This publication contains information, advice and guidance to help members of the RCN. It is intended for use within the UK but readers are advised that practices may vary in each country and outside the UK. The information in this publication has been compiled from professional sources, but its acc ...
... This publication contains information, advice and guidance to help members of the RCN. It is intended for use within the UK but readers are advised that practices may vary in each country and outside the UK. The information in this publication has been compiled from professional sources, but its acc ...
American Diabetes Association
... • HDL cholesterol level <35 mg/dL (0.90 mmol/L) and/or a triglyceride level >250 mg/dL (2.82 mmol/L) • Women with polycystic ovarian syndrome (PCOS) • A1C ≥5.7%, IGT, or IFG on previous testing • Other clinical conditions associated with insulin resistance (e.g., severe obesity, acanthosis nigricans ...
... • HDL cholesterol level <35 mg/dL (0.90 mmol/L) and/or a triglyceride level >250 mg/dL (2.82 mmol/L) • Women with polycystic ovarian syndrome (PCOS) • A1C ≥5.7%, IGT, or IFG on previous testing • Other clinical conditions associated with insulin resistance (e.g., severe obesity, acanthosis nigricans ...
A Recommendations
... • HDL cholesterol level <35 mg/dL (0.90 mmol/L) and/or a triglyceride level >250 mg/dL (2.82 mmol/L) • Women with polycystic ovarian syndrome (PCOS) • A1C ≥5.7%, IGT, or IFG on previous testing • Other clinical conditions associated with insulin resistance (e.g., severe obesity, acanthosis nigricans ...
... • HDL cholesterol level <35 mg/dL (0.90 mmol/L) and/or a triglyceride level >250 mg/dL (2.82 mmol/L) • Women with polycystic ovarian syndrome (PCOS) • A1C ≥5.7%, IGT, or IFG on previous testing • Other clinical conditions associated with insulin resistance (e.g., severe obesity, acanthosis nigricans ...
Gestational diabetes
Gestational diabetes (or gestational diabetes mellitus, GDM) is a condition in which women without previously diagnosed diabetes exhibit high blood glucose (blood sugar) levels during pregnancy (especially during their third trimester). Gestational diabetes is caused when insulin receptors do not function properly. This is likely due to pregnancy-related factors such as the presence of human placental lactogen that interferes with susceptible insulin receptors. This in turn causes inappropriately elevated blood sugar levels.Gestational diabetes generally has few symptoms and it is most commonly diagnosed by screening during pregnancy. Diagnostic tests detect inappropriately high levels of glucose in blood samples. Gestational diabetes affects 3-10% of pregnancies, depending on the population studied.As with diabetes mellitus in pregnancy in general, babies born to mothers with untreated gestational diabetes are typically at increased risk of problems such as being large for gestational age (which may lead to delivery complications), low blood sugar, and jaundice. If untreated, it can also cause seizures or stillbirth. Gestational diabetes is a treatable condition and women who have adequate control of glucose levels can effectively decrease these risks. The food plan is often the first recommended target for strategic management of GDM.Women with unmanaged gestational diabetes are at increased risk of developing type 2 diabetes mellitus (or, very rarely, latent autoimmune diabetes or Type 1) after pregnancy, as well as having a higher incidence of pre-eclampsia and Caesarean section; their offspring are prone to developing childhood obesity, with type 2 diabetes later in life. Most women are able to manage their blood glucose levels with a modified diet and the introduction of moderate exercise, but some require antidiabetic drugs, including insulin.